Hello Friends, I have came across a site who provides you patent study of different fields like pharmacy, chemical, engineering etc and you have to submit the prior arts searches related to that patent subject as described by them and if you provide most useful prior arts you can get rewards minimum 5000$ to 10000$. Registration is free at this link

I have came across an institute which provides class room coaching and online distance learning module for "Indian Patent Agent Exam", an exam conducted by Indian Patent office and authorized by Indian Government at very reasonable fees. Class room coaching/Online distance learning module will cover * Indian patent law * Drafting of patent specification & licence agreements

I have come across so many students of M.pharm and phD, who are crazy about the publication in national as well as international journals. But they forgot the research value of their hard work. Publication just give them a list of publication with his/her name and nothing else as a motivation. second thing any one can use that research data and manipulate for his own purpose either commercial or non commercial.

Its really strange but its the fact that europen union is gong to ban the herbal drugs from all european union from April 2011 under the The European Directive on Traditional Herbal Medicinal Products (THMPD). In current scenario all other countries moving towards natural and herbal therapy, EU is going opposite to them. For further details please click below link

Lincoln Pharmaceuticals Limited (LPL), an Ahmedabad-based company has been granted a patent for a nasal spray, by indian patent office which would help in preventing vomiting and nausea.

The highest sold drug in US is Lipitor and generics are behind that to make business. Earlier this drugs's patent was challenged by many including Ranbaxy and as a results few settled the case with some kind of agreement and few lost the case.

Mylan Inc.has received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for Nisoldipine Extended-release Tablets, 8.5 mg, 17 mg, 25.5 mg and 34 mg. Earlier Mylan has developed the different strengths like 20 mg, 30 mg and 40 mg but later discontinued from the market.

Patent Search Patent searches is carried out for any of the below reasons.... -Patentability analysis -State of the art (Prior art) for invalidation -Solution of technical issue -Freedom to operate analysis -Stimulate new invention -To avoid reinventing the wheel -Competitor patent analysis -Worldwide technology trend analysis

INTUNIV(TM) is product of Shire plc and contains 1 mg, 2 mg, 3 mg, and 4 mg guanfacine hydrochloride extended release tablets. This product has 3 patents listed in orange book; US5854290 ("the '290 patent") titled Use of Guanfacine in the Treatment of Behavioral Disorders; US6287599 ("the '599 patent") and US6811794 ("the '794 patent") both titled Sustained Release Pharmaceutical Dosage Forms with Minimized pH Dependent Dissolution Profiles. The three patents expire in 2015, 2020 and 2022, respectfully.

USFDA has finally given the green light to Allergan for its product Botox injection (onabotulinumtoxinA) for the new indication that is prevention of headaches associated with chronic migraine in adult patients. As per the survey this new indication is going to add $ 1 billion to the existing annual sales of $1.3 billion.